Highlights
NASDAQ: UTHR       United Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
132.18   +2.42 (1.86%)  129.53 - 134.10  312,137

Overview

 
Avg Volume (4 weeks):604,615
4 Weeks Range:123.05 - 137.82
4 Weeks Price Volatility (%):
61.81%
52 Weeks Range:110.90 - 169.89
52 Weeks Price Volatility (%):
36.07%
Average Price Target: 147.00
Price Target Upside/Downside: +14.82

Headlines



No recent Headlines for this stock.


Business Background

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution (Tyvaso); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). The Company markets and sells an oncology product in the United States, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of neuroblastoma. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies.

  Be the first to like this.
 


 

3838  3083  647  864 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DCTH 0.139+0.036 
 VXX 11.84+0.01 
 AMD 12.70-0.32 
 IDXG 1.35+0.27 
 SRC 8.62+0.14 
 SPY 246.94+0.43 
 URBN 19.841+3.021 
 VALE 10.03+0.25 
 BAC 24.351-0.119 
 SNAP 13.15+0.41 
Partners & Brokers